MRC1 and neoplasm: On the other hand, while MMR deficiencies are relatively uncommon in LUAD, their presence often results in a high tumor mutational burden (TMB), facilitating neoantigen formation and increasing sensitivity to immune checkpoint inhibitors (ICIs).